Hemolysis interferes in the measurement of plasma biomakers of oxidative stress in dogs

• Autor(a) principal: Morais, L. [UNESP]
• Data de Publicação: 2018
• Outros Autores: Bosco, A. M. [UNESP], Baptisttiolli, L. [UNESP], Torrecilha, R. B. P. [UNESP], Valadares, T. C. [UNESP], Hoffmann, D. J. [UNESP], Ciarlini, P. C. [UNESP]
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1590/1678-4162-9398; http://hdl.handle.net/11449/160456
• topic: analytical error; antioxidant; bias; hemoglobin; oxidant

Among all the various sources of analytical error, hemolysis is the most important in the laboratory routine. The present study aimed to investigate the effect of hemolysis in vitro on the main plasma biomarkers of oxidative stress (BPEO) dogs. For this purpose, whole blood samples from 19 healthy dogs were hemolyzed in different degrees by mechanical action. Control samples containing low concentration of hemoglobin (Hb) levels in plasma were compared with four degrees of hemolysis (<0.36, from 0.36 to 0.60, 0.61 to 1.0, 1.1 to 4g/L Hb). Immediately after causing hemolysis, plasma concentrations of uric acid (UA), albumin, bilirubin, gamma glutamyl transferase (GGT), total antioxidant capacity (TAC), and total oxidant concentration (TOC) were measured. The relative errors caused by several levels of hemolysis were calculated and compared with the total acceptable error (TAE) and allowed error limit (LEP) by employees in quality control programs for laboratory tests. Even small levels of hemolysis generate unacceptable analytical error (TAE and / or LEP) in BPEO measured, except for bilirubin. Hemolysis is a limiting factor for the assessment of systemic oxidative stress measured in plasma and may cause errors that potentially compromise clinical diagnosis.